Holen Sie sich die Stockscreener-App
0.964
3.60%
-0.036
Handel nachbörslich:
.99
0.026
+2.70%
Oncolytics Biotech Inc Aktie (ONCY) Neueste Nachrichten
Aug Spikes: Can Oncolytics Biotech Inc expand its profit marginsMarket Trend Summary & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Patterns Watch: How is Oncolytics Biotech Inc managing supply chain issuesJuly 2025 PreEarnings & Community Consensus Trade Signals - baoquankhu1.vn
Smart Money: What is Oncolytics Biotech Incs 5 year growth outlookMarket Movers & Community Verified Trade Signals - baoquankhu1.vn
Registration Momentum Builds Across the Oncology Pipeline - The Globe and Mail
Public market insider buying at Oncolytics Biotech (ONC) - The Globe and Mail
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else - PR Newswire
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else - Benzinga
Assessing Oncolytics Biotech (ONCY) Valuation After FDA Fast Track Designation For Pelareorep - Yahoo Finance
Why Oncolytics Biotech (ONCY) Is Up 19.7% After FDA Fast Track For KRAS-Mutant Colorectal Cancer - Yahoo Finance
Oncolytics Biotech Inc. (NASDAQ:ONCY) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Oncolytics Biotech (ONCY) Is Up 19.7% After FDA Fast Track For KRAS-Mutant mCRC Regimen - Sahm
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Oncolytics Biotech (NASDAQ:ONCY) Insider Purchases $25,456.00 in Stock - MarketBeat
Insider Buying: Oncolytics Biotech (NASDAQ:ONCY) CEO Acquires 29,500 Shares of Stock - MarketBeat
Oncolytics Biotech (NASDAQ:ONCY) Director Purchases $34,000.00 in Stock - MarketBeat
Oncolytics Biotech (NASDAQ:ONCY) CFO Kirk Look Acquires 12,000 Shares - MarketBeat
Oncolytics Biotech (NASDAQ:ONCY) Director Wayne Pisano Buys 30,000 Shares - MarketBeat
Oncolytics Biotech (NASDAQ:ONCY) Insider Thomas Charles Heineman Purchases 12,132 Shares - MarketBeat
Deborah Margaret Brown Buys 25,000 Shares of Oncolytics Biotech (NASDAQ:ONCY) Stock - MarketBeat
Will Oncolytics Biotech Inc. outperform tech stocksChart Signals & Weekly High Return Opportunities - mfd.ru
Why retail investors favor Oncolytics Biotech Inc. stockWeekly Trade Review & Detailed Earnings Play Strategies - mfd.ru
Oncolytics Biotech (NASDAQ:ONCY) Trading 1.3% HigherHere's Why - MarketBeat
Is Oncolytics Biotech Inc. forming a breakout patternMarket Trend Summary & Reliable Breakout Forecasts - mfd.ru
Precision Biologics Market Awakens to $71 Billion Opportunity - Intellectia AI
Analysts’ Top Healthcare Picks: Oncolytics Biotech (ONCY), NeuroPace (NPCE) - The Globe and Mail
New Highs: How sensitive is Oncolytics Biotech Inc to inflation2025 Bull vs Bear & Safe Capital Growth Stock Tips - baoquankhu1.vn
Oncolytics Biotech Forms Advisory Board to Advance Pelareorep in GI Cancers - MSN
Oncolytics Biotech Receives FDA Fast Track Designation - Intellectia AI
$207B Market Shift: The Race for Fast Track Approval in Oncology - Investing News Network
Oncolytics Biotech Inc - Baystreet.ca
Stocks in play: Oncolytics Biotech Inc - Barchart.com
The $71 Billion Cancer Shift: Why The FDA Is Speeding Up - GlobeNewswire
Oncolytics receives FDA Fast Track Designation for pelareorep - Yahoo Finance
ONCY stock rallies on second fast track designation for experimental cancer drug - MSN
Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Yahoo Finance
Oncolytics Biotech receives FDA Fast Track for pelareorep - TipRanks
Oncolytics Biotech Inc Receives FDA Fast Track Designation for Pelareorep - TradingView
ONCY Stock Rallies On Second Fast Track Designation For Experimental Cancer Drug - Stocktwits
Oncolytics Biotech receives FDA fast track designation for pelareorep in 2L KRAS-mutant MSS metastatic colorectal cancer - marketscreener.com
Oncolytics Biotech (ONCY) Secures FDA Fast Track for Cancer Trea - GuruFocus
Oncolytics surges on Fast Track status for pelareorep in colorectal cancer - Seeking Alpha
Oncolytics Biotech stock soars after FDA grants Fast Track Designation By Investing.com - Investing.com South Africa
Oncolytics Biotech stock soars after FDA grants Fast Track Designation - Investing.com
Oncolytics (ONCY) Secures FDA Fast Track for Innovative Cancer T - GuruFocus
Oncolytics Biotech Showcases Promising Immunotherapy Advancements - timothysykes.com
FDA grants fast track designation to Oncolytics’ pelareorep for colorectal cancer - Investing.com
Oncolytics Biotech® Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer - The Manila Times
Oncolytics Biotech Receives Fast Track Designation for Pelareorep in Second-Line KRAS-Mutant MSS Metastatic Colorectal Cancer Following Promising Clinical Data - Quiver Quantitative
Oncolytics Biotech® Receives FDA Fast Track Designation for - GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
EPS Watch: Can Oncolytics Biotech Inc expand its profit marginsQuarterly Trade Summary & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Stock Report: Is Oncolytics Biotech Inc forming a breakout pattern - baoquankhu1.vn
0.34%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):